Local delivery of amyloid beta oligomers from the tip of a nanopipette, controlled over the cell surface, has been used to deliver physiological picomolar oligomer concentrations to primary astrocytes or neurons. Calcium influx was observed when as few as 2000 oligomers were delivered to the cell surface. When the dosing of oligomers was stopped the intracellular calcium returned to basal levels or below. Calcium influx was prevented by the presence in the pipette of the extracellular chaperone clusterin, which is known to selectively bind oligomers, and by the presence a specific nanobody to amyloid beta. These data are consistent with individual oligomers larger than trimers inducing calcium entry as they cross the cell membrane, a result...
Amyloid-β (Aβ) oligomers are toxic species implicated in Alzheimer's disease (AD). The prevailing hy...
BACKGROUND: To better understand the complex molecular level interactions seen in the pathogenesis o...
In recent years, the prevalence of amyloid neurodegenerative diseases such as Alzheimer's disease (A...
Resumen del póster presentado al Joint FEPS & XXXVI Spanish Physiological Society Congress (Sociedad...
Background: Amyloid-β oligomers (oAβ) are thought to mediate neurotoxicity in Alzheimer’s disease (A...
Understanding how amyloid-b peptide interacts with living cells on a molecular level is critical to ...
Understanding how amyloid-β peptide interacts with living cells on a molecular level is critical to ...
The molecular basis of amyloid toxicity in Alzheimer’s disease (AD) remains controversial. Amyloid β...
Objective and tasks. The aim of this study is to investigate the effects of Aβ1-40 and Aβ1-42 peptid...
The molecular basis of amyloid toxicity in Alzheimer’s disease (AD) remains controversial. Amyloid β...
Nanosized objects are increasingly present in everyday life and in specialized technological applica...
Oligomers of the amyloid β peptide (Aβo) are becoming the most likely neurotoxin in Alzheimer’s dise...
Soluble oligomers of amyloid-beta peptide have been implicated as the proximal neurotoxins in Alzhei...
Producción CientíficaOligomers of the amyloid peptide (A o) are becoming the most likely neurotoxi...
Accumulation of amyloid-beta (A beta) peptides correlates with aging and progression of Alzheimer's ...
Amyloid-β (Aβ) oligomers are toxic species implicated in Alzheimer's disease (AD). The prevailing hy...
BACKGROUND: To better understand the complex molecular level interactions seen in the pathogenesis o...
In recent years, the prevalence of amyloid neurodegenerative diseases such as Alzheimer's disease (A...
Resumen del póster presentado al Joint FEPS & XXXVI Spanish Physiological Society Congress (Sociedad...
Background: Amyloid-β oligomers (oAβ) are thought to mediate neurotoxicity in Alzheimer’s disease (A...
Understanding how amyloid-b peptide interacts with living cells on a molecular level is critical to ...
Understanding how amyloid-β peptide interacts with living cells on a molecular level is critical to ...
The molecular basis of amyloid toxicity in Alzheimer’s disease (AD) remains controversial. Amyloid β...
Objective and tasks. The aim of this study is to investigate the effects of Aβ1-40 and Aβ1-42 peptid...
The molecular basis of amyloid toxicity in Alzheimer’s disease (AD) remains controversial. Amyloid β...
Nanosized objects are increasingly present in everyday life and in specialized technological applica...
Oligomers of the amyloid β peptide (Aβo) are becoming the most likely neurotoxin in Alzheimer’s dise...
Soluble oligomers of amyloid-beta peptide have been implicated as the proximal neurotoxins in Alzhei...
Producción CientíficaOligomers of the amyloid peptide (A o) are becoming the most likely neurotoxi...
Accumulation of amyloid-beta (A beta) peptides correlates with aging and progression of Alzheimer's ...
Amyloid-β (Aβ) oligomers are toxic species implicated in Alzheimer's disease (AD). The prevailing hy...
BACKGROUND: To better understand the complex molecular level interactions seen in the pathogenesis o...
In recent years, the prevalence of amyloid neurodegenerative diseases such as Alzheimer's disease (A...